Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Hypoxia × Temozolomide × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 11 Glioma 4 Medulloblastoma 2 Triple Negative Breast Neoplasms 1 Solid Tumor Cancer 1 Sarcoma, Ewing 1 SCLC, Extensive Stage 1 Recurrence 1 Primary Glioblastoma 1 Lymphoma, Follicular 1 Hypoxia 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

fludarabine 1 Temozolomide 1 Radiotherapy 1 Injections 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06477939 2024-06-27

THREE-GLEES

Institut de cancérologie Strasbourg Europe

Phase 3 Not yet recruiting

Hypoxia, Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡